天上的闪亮的星星在胃粘膜上
Kosuke Minaga1, Hajime Honjo1, Tomohiro Watanabe1
1Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine Osaka-Sayama Japan.
Journal of general and family medicine
|July 11, 2025
概括
本案例研究详细介绍了一例罕见的零星性胃伯基特淋巴瘤病例,该病例发生在一名日本老年男性身上. 在胃病变中,特有的"星空"组织病理学证实了诊断.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 胃伯基特淋巴瘤是一种非常罕见的非霍奇金淋巴瘤.
- 零星形式比特有的形式更常见,特别是在西方国家.
- 诊断往往依赖于特征性的组织病理学发现.
研究的目的:
- 报告一位日本老年患者罕见的偶发性胃伯基特淋巴瘤病例.
- 突出诊断挑战和特征性组织病理特征.
- 为胃淋巴瘤流行病学的文献做出贡献.
主要方法:
- 消化管-胃管-肠膜镜检查用于视觉检查胃病变.
- 胃组织的活检和组织病理学检查.
- 显微镜分析以确定细胞形态和模式.
主要成果:
- 消化管-胃管-骨镜检查显示了胃的较小曲线中的结节和性病变.
- 病理学分析表明,非典型的淋巴细胞密集透,这是伯基特淋巴瘤的特征.
- "星空"的外观,由于分散的巨细胞,是一个关键的诊断特征.
结论:
- 偶发性胃伯基特淋巴瘤虽然很少见,但应在胃恶性瘤的差异诊断中考虑.
- "星空"模式是诊断胃伯基特淋巴瘤的关键组织病理标志.
- 早期诊断和适当的治疗对于改善患者的治疗结果至关重要.
相关概念视频
Mucosal Barrier of the Stomach
847
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
847
Gastritis-II: Pathophysiology
579
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
579
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
593
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
593
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
719
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
719
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
600
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
600
Peptic Ulcer Disease II: Pathophysiology
878
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
878


